Back

Association of colchicine with cardiovascular outcomes in patients with acute coronary syndrome

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Lipid-lowering and inflammation Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Michael Tao

Hartford Hospital, Hartford (United States of America)

7 More presentations in this session

Presentation thumbnail
Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)
Doctor A. Bech-Drewes (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Healed plaque and systemic thrombogenicity in patients with chronic coronary syndrome
Doctor D. Kinoshita (Yamagata, JP)
Abstract Slides Video
Presentation thumbnail
Effects of vitamin k2 and d3 supplementation on cardiac and systemic inflammation: a randomized controlled trial
Doctor S. Hasific (Odense, DK)
Abstract Slides Video
Presentation thumbnail
The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease
Mr C. Coerkamp (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Emerging role of inflammatory pathways on coronary atherosclerotic risk in patients with chronic coronary syndromes under current treatment
Doctor C. Caselli (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid-lowering and inflammation

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Colchicine in acute coronary syndrome: an updated meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Colchicine in acute coronary syndromes: a meta-analysis of 12.602 patients
thumbnail
Congress Presentation
Association of colchicine with atrial fibrillation and safety outcomes in patients with acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources